|
|
| Research article summary (published 8 Sep 2009): |
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
Full Abstract
MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessing good physicochemical properties. In pharmacological studies, the compound was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good dose response. This compound also exhibited oral efficacy in a naturally Ascaris-sensitized sheep asthma model showing significant inhibition of the late phase response to allergen challenge. This compound has been considered for further development as a treatment therapy for asthma.
Author information
Author/s: Li, Wei (W); Li, Jianchang (J); Wu, Yuchuan (Y); Rancati, Fabio (F); Vallese, Stefania (S); Raveglia, Luca (L); Wu, Junjun (J); Hotchandani, Rajeev (R); Fuller, Nathan (N); Cunningham, Kristina (K); Morgan, Paul (P); Fish, Susan (S); Krykbaev, Rustem (R); Xu, Xin (X); Tam, Steve (S); Goldman, Samuel J (SJ); Abraham, William (W); Williams, Cara (C); Sypek, Joseph (J); Mansour, Tarek S (TS);
Affiliation: Chemical Sciences, Wyeth Research, Cambridge, Massachusetts 02140, USA. weili(-atsign-)wyeth.com
Journal and publication information
Publication Type: Journal Article
Journal: Journal of medicinal chemistry (J Med Chem), published in United States. (Language: eng)
Reference: 2009-Sep; vol 52 (issue 17) : pp 5408-19
Dates: Created 2009/09/03; Completed 2009/09/25;
PMID: 19725580, status: MEDLINE (last retrieval date: 9/25/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke.
17 May 2008 - Prevention of elastase-induced experimental emphysema by a synthetic elastase inhibitor administered orally.
30 Dec 1979 - Antitrypsin activity of extracts from Ecballium elaterium seeds.
7 Feb 2008 - Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives.
5 Jun 2004 - Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases.
31 Jan 2007 - Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors.
15 Aug 2006 - Identification of potent and selective MMP-13 inhibitors.
13 Sep 2005 - Bortezomib-based combinations in the treatment of non-small-cell lung cancer.
29 Sep 2005 - Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors.
3 Dec 2005 - Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor.
17 Apr 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.